Received Apr 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 553J7 | — |
A 13 years old female patient received an expired dose of Engerix-B; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 13-year-old female patient who received HBV (Engerix B) (batch number 553J7, expiry date 28-MAR-2025) for prophylaxis. On 22-APR-2025, the patient received Engerix B. On 22-APR-2025, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: A 13 years old female patient received an expired dose of Engerix-B). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 23-APR-2025 The medical assistant report that a patient received an expired dose of Engerix-B which led to, expired vaccine used. The reporter had a questioned did they need to revaccinate the patient.